These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 23970926)
1. The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia. Ridolfi E; Barone C; Scarpini E; Galimberti D Clin Dev Immunol; 2013; 2013():939786. PubMed ID: 23970926 [TBL] [Abstract][Full Text] [Related]
2. Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration. Woollacott IOC; Toomey CE; Strand C; Courtney R; Benson BC; Rohrer JD; Lashley T J Neuroinflammation; 2020 Aug; 17(1):234. PubMed ID: 32778130 [TBL] [Abstract][Full Text] [Related]
3. Patterns of Microglial Cell Activation in Alzheimer Disease and Frontotemporal Lobar Degeneration. Taipa R; Brochado P; Robinson A; Reis I; Costa P; Mann DM; Melo Pires M; Sousa N Neurodegener Dis; 2017; 17(4-5):145-154. PubMed ID: 28445885 [TBL] [Abstract][Full Text] [Related]
4. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Thijssen EH; La Joie R; Strom A; Fonseca C; Iaccarino L; Wolf A; Spina S; Allen IE; Cobigo Y; Heuer H; VandeVrede L; Proctor NK; Lago AL; Baker S; Sivasankaran R; Kieloch A; Kinhikar A; Yu L; Valentin MA; Jeromin A; Zetterberg H; Hansson O; Mattsson-Carlgren N; Graham D; Blennow K; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Teunissen CE; Rabinovici GD; Rojas JC; Dage JL; Boxer AL; Lancet Neurol; 2021 Sep; 20(9):739-752. PubMed ID: 34418401 [TBL] [Abstract][Full Text] [Related]
5. Clinical accuracy of the distinction between Alzheimer's disease and frontotemporal lobar degeneration. Sutovsky S; Blaho A; Kollar B; Siarnik P; Csefalvay Z; Dragasek J; Turcani P Bratisl Lek Listy; 2014; 115(3):161-7. PubMed ID: 24579686 [TBL] [Abstract][Full Text] [Related]
7. Microglial Activation and Priming in Alzheimer's Disease: State of the Art and Future Perspectives. Bivona G; Iemmolo M; Agnello L; Lo Sasso B; Gambino CM; Giglio RV; Scazzone C; Ghersi G; Ciaccio M Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614325 [TBL] [Abstract][Full Text] [Related]
8. Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and frontotemporal lobar degeneration: a real-time PCR study. Vignini A; Morganti S; Salvolini E; Sartini D; Luzzi S; Fiorini R; Provinciali L; Di Primio R; Mazzanti L; Emanuelli M Exp Gerontol; 2013 Dec; 48(12):1505-8. PubMed ID: 24400342 [TBL] [Abstract][Full Text] [Related]
9. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease. Webers A; Heneka MT; Gleeson PA Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430 [TBL] [Abstract][Full Text] [Related]
12. ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration. Cousins KAQ; Irwin DJ; Wolk DA; Lee EB; Shaw LMJ; Trojanowski JQ; Da Re F; Gibbons GS; Grossman M; Phillips JS Brain; 2020 Jul; 143(7):2295-2311. PubMed ID: 32666090 [TBL] [Abstract][Full Text] [Related]
13. Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol. Bocchetta M; Mega A; Bernardi L; Di Maria E; Benussi L; Binetti G; Borroni B; Colao R; Di Fede G; Fostinelli S; Galimberti D; Gennarelli M; Ghidoni R; Piaceri I; Pievani M; Porteri C; Redaelli V; Rossi G; Suardi S; Babiloni C; Scarpini E; Tagliavini F; Padovani A; Nacmias B; Sorbi S; Frisoni GB; Bruni AC; J Alzheimers Dis; 2016; 51(1):277-91. PubMed ID: 26901402 [TBL] [Abstract][Full Text] [Related]
14. Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models. Minami SS; Min SW; Krabbe G; Wang C; Zhou Y; Asgarov R; Li Y; Martens LH; Elia LP; Ward ME; Mucke L; Farese RV; Gan L Nat Med; 2014 Oct; 20(10):1157-64. PubMed ID: 25261995 [TBL] [Abstract][Full Text] [Related]
15. Targeting innate immunity for neurodegenerative disorders of the central nervous system. Andreasson KI; Bachstetter AD; Colonna M; Ginhoux F; Holmes C; Lamb B; Landreth G; Lee DC; Low D; Lynch MA; Monsonego A; O'Banion MK; Pekny M; Puschmann T; Russek-Blum N; Sandusky LA; Selenica ML; Takata K; Teeling J; Town T; Van Eldik LJ J Neurochem; 2016 Sep; 138(5):653-93. PubMed ID: 27248001 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. Goossens J; Bjerke M; Van Mossevelde S; Van den Bossche T; Goeman J; De Vil B; Sieben A; Martin JJ; Cras P; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S Alzheimers Res Ther; 2018 Mar; 10(1):31. PubMed ID: 29559004 [TBL] [Abstract][Full Text] [Related]
17. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology. Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351 [TBL] [Abstract][Full Text] [Related]
18. Comparing the driving behaviours of individuals with frontotemporal lobar degeneration and those with Alzheimer's disease. Fujito R; Kamimura N; Ikeda M; Koyama A; Shimodera S; Morinobu S; Inoue S Psychogeriatrics; 2016 Jan; 16(1):27-33. PubMed ID: 25735319 [TBL] [Abstract][Full Text] [Related]